These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


317 related items for PubMed ID: 9705576

  • 1. Role of glucocorticoids in the modulation of corticotropin-releasing hormone mRNA level by the endogenous benzodiazepine receptor ligand octadecaneuropeptide in rat brain.
    Givalois L, Li S, Pelletier G.
    Neuroendocrinology; 1998 Aug; 68(2):98-104. PubMed ID: 9705576
    [Abstract] [Full Text] [Related]

  • 2. The octadecaneuropeptide-induced response of corticotropin-releasing hormone messenger RNA levels is mediated by GABA(A) receptors and modulated by endogenous steroids.
    Givalois L, Grinevich V, Li S, Garcia-De-Yebenes E, Pelletier G.
    Neuroscience; 1998 Jul; 85(2):557-67. PubMed ID: 9622252
    [Abstract] [Full Text] [Related]

  • 3. Role of adrenal and gonadal steroids in the response of GnRH gene expression to the endogenous benzodiazepine receptor ligand octadecaneuropeptide in the male rat brain.
    Li S, Givalois L, Pelletier G.
    Neuropeptides; 1997 Oct; 31(5):463-8. PubMed ID: 9413024
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Differential involvement of adrenal and gonadal steroids in anterior and intermediate pituitary pro-opiomelanocortin mRNA expression induced by the endogenous benzodiazepine, octadecaneuropeptide, in adult male rats.
    Givalois L, Li S, Pelletier G.
    J Endocrinol; 1999 May; 161(2):307-16. PubMed ID: 10320829
    [Abstract] [Full Text] [Related]

  • 8. Effect of intracerebroventricular administration of the octadecaneuropeptide on the expression of pro-opiomelanocortin, neuropeptide Y and corticotropin-releasing hormone mRNAs in rat hypothalamus.
    Compère V, Li S, Leprince J, Tonon MC, Vaudry H, Pelletier G.
    J Neuroendocrinol; 2003 Feb; 15(2):197-203. PubMed ID: 12535162
    [Abstract] [Full Text] [Related]

  • 9. Increased expression of corticotropin-releasing hormone and vasopressin messenger ribonucleic acid (mRNA) in the hypothalamic paraventricular nucleus during repeated stress: association with reduction in glucocorticoid receptor mRNA levels.
    Makino S, Smith MA, Gold PW.
    Endocrinology; 1995 Aug; 136(8):3299-309. PubMed ID: 7628364
    [Abstract] [Full Text] [Related]

  • 10. CRH mRNA expression in the hypothalamic paraventricular nucleus is inhibited despite the activation of the hypothalamo-pituitary-adrenal axis during starvation.
    Nishiyama M, Makino S, Iwasaki Y, Tanaka Y, Nazarloo HP, Kaneda T, Asaba K, Hashimoto K.
    Brain Res; 2008 Sep 04; 1228():107-12. PubMed ID: 18619422
    [Abstract] [Full Text] [Related]

  • 11. Regulation of proopiomelanocortin gene expression by endogenous ligands of the GABAA receptor complex as evaluated by in situ hybridization in the rat pars intermedia.
    Garcia de Yebenes E, Li S, Pelletier G.
    Brain Res; 1997 Mar 07; 750(1-2):277-84. PubMed ID: 9098553
    [Abstract] [Full Text] [Related]

  • 12. Regulation of pituitary corticotropin releasing hormone (CRH) receptor mRNA and CRH binding during adrenalectomy: role of glucocorticoids and hypothalamic factors.
    Rabadan-Diehl C, Makara G, Kiss A, Zelena D, Aguilera G.
    J Neuroendocrinol; 1997 Sep 07; 9(9):689-97. PubMed ID: 9355036
    [Abstract] [Full Text] [Related]

  • 13. Androgens alter corticotropin releasing hormone and arginine vasopressin mRNA within forebrain sites known to regulate activity in the hypothalamic-pituitary-adrenal axis.
    Viau V, Soriano L, Dallman MF.
    J Neuroendocrinol; 2001 May 07; 13(5):442-52. PubMed ID: 11328455
    [Abstract] [Full Text] [Related]

  • 14. Differential regulation of corticotropin-releasing hormone and vasopressin transcription by glucocorticoids.
    Ma XM, Aguilera G.
    Endocrinology; 1999 Dec 07; 140(12):5642-50. PubMed ID: 10579328
    [Abstract] [Full Text] [Related]

  • 15. Central LPS-induced c-fos expression in the PVN and the A1/A2 brainstem noradrenergic cell groups is altered by adrenalectomy.
    Condé GL, Renshaw D, Zubelewicz B, Lightman SL, Harbuz MS.
    Neuroendocrinology; 1999 Sep 07; 70(3):175-85. PubMed ID: 10516480
    [Abstract] [Full Text] [Related]

  • 16. Regulation of messenger ribonucleic acid for corticotropin releasing hormone receptor in the pituitary during stress.
    Rabadan-Diehl C, Kiss A, Camacho C, Aguilera G.
    Endocrinology; 1996 Sep 07; 137(9):3808-14. PubMed ID: 8756551
    [Abstract] [Full Text] [Related]

  • 17. Gonadal steroids exert facilitating and "buffering" effects on glucocorticoid-mediated transcriptional regulation of corticotropin-releasing hormone and corticosteroid receptor genes in rat brain.
    Patchev VK, Almeida OF.
    J Neurosci; 1996 Nov 01; 16(21):7077-84. PubMed ID: 8824343
    [Abstract] [Full Text] [Related]

  • 18. Role of androgens and glucocorticoids in the regulation of diazepam-binding inhibitor mRNA levels in male mouse hypothalamus.
    Compère V, Ouellet J, Luu-The V, Dureuil B, Tonon MC, Vaudry H, Labrie F, Pelletier G.
    Brain Res; 2006 Nov 13; 1119(1):50-7. PubMed ID: 16963002
    [Abstract] [Full Text] [Related]

  • 19. Further studies on the mechanism of action of the endogenous benzodiazepine receptor ligand octadecaneuropeptide on gonadotropin-releasing hormone gene expression in the rat brain.
    Li S, Pelletier G.
    Neuroendocrinology; 1996 Aug 13; 64(2):79-84. PubMed ID: 8857601
    [Abstract] [Full Text] [Related]

  • 20. Involvement of neurosteroids in the effect of the endogenous benzodiazepine receptor ligand octadecaneuropeptide (ODN) on gonadotropin-releasing hormone gene expression in rat brain.
    Li S, Givalois L, Pelletier G.
    J Neuroendocrinol; 1997 Mar 13; 9(3):229-33. PubMed ID: 9089474
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.